Bluebird Bio Withdraws Zynteglo From Germany Over Pricing
Germany Is The Only Country Where the Gene Therapy Was Marketed
After arbitrators set an unpalatably low price for the company, bluebird is withdrawing its Zyntgelo gene therapy from Germany. The company also announced it would be restructuring its workforce, with job losses expected.
